Kaynaklar
1. Sonis TS, Faizo CR, Fang L. Oral Medicine. 2nd ed.
Philadelphia: WB Saunders Co, 1995: 364-365.
2. Fang M, Zhang W, Chen Y, He Z. Malignant
transformation of oral lichen planus: a retrospective
study of 23 cases. Quint Int 2009; 40: 235-242.
3. Cawson RA, Odell EW, Porter S. Disease of the oral
mucosa: Non-infective stomatitis. In: Cawson RA,
Odell EW, Porter S (eds). Cawson’s Essentials of
Oral Pathology and Oral Medicine. 7th ed. London:
Churchill Livingstone, 2002: 197-199.
4. Gedik R, Arıcı S, Hah Marufi. Lichen planus: Case
report. J Cumhuriyet University Dental Faculty 2000; 3:
44-46.
5. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom
K. Number V oral lichen planus: clinical features and
management. Oral Dis 2005; 11: 338-349.
6. Van der Hem PS, Egges M, van der Wal JE, Roodenburg
JL. CO2 laser evaporation of oral lichen planus. Int J
Oral Maxillofac Surg 2008; 37: 630-633.
7. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective
follow-up study of 570 patients with oral lichen planus:
persistence, remission, and malignant association. Oral
Surg Oral Med Oral Pathol 1985; 60: 30-34.
8. Bilen N. Problems in eroziv lichen planus treatment. T
Klin J Int Med Sci 2005; 1: 156-160.
9. Rodstrom PO, Jontell M, Mattsson U, Holmberg E.
Cancer and oral lichen planus in a Swedish population.
Oral Oncol 2004; 40: 131–138.
10. Scully C, Carrozo M. Oral mucosal disease: Lichen
Planus. Br J Oral Maxillofac Surg 2008; 46: 15-21.
11. Thongprasom K, Luengvisut P, Wongwatanakij A,
Boonjatturus C. Clinical evaluation in treatment of oral
lichen planus with topical fluocinolone acetonide: a
2-year follow-up. J Oral Pathol Med 2003; 32: 315-322.
12. Nolan A, Badminton J, Maguire J, Seymour RA. The
efficacy of topical hyaluronic acid in the management
of oral lichen planus. J Oral Pathol Med 2009; 38:
299-303.
13. Altınyazar C, Şaşmaz R, Aksoy D, Çelebi CR, Sakman
M, Eskioğlu F. Ulcerative oral lichen planus treated by
topical siclosporin-A. T Klin Dermatol 1996; 6: 40-42.
14. Scully C, Eisen D, Carrozzo M. Management of oral
lichen planus. Am J Clin Dermatol 2000; 1: 287-306.
15. Lundstrom IM. Incidence of diabetus mellitus in
patients with oral lichen planus. Int J Oral Surg 1983;
12: 147-152.
16. Soto Araya M, Rojas Alcayaga G, Esguep A. Association
between psychological disorders and the presence of
Oral lichen planus, Burning mouth syndrome and
Recurrent aphthous stomatitis. Med Oral 2004; 9: 1-7.
17. Pakfetrat A, Javadzadeh-Bolouri A, Basir-Shabestari S,
Falaki F. Oral Lichen Planus: a retrospective study of
420 Iranian patients. Med Oral Patol Oral Cir Bucal
2009; 14: E315-E318.
18. Neumann-Jensen B, Holmstrup P, Pindborg JJ. Smoking
habits of 611 patients with oral lichen planus. Oral Surg
Oral Med Oral Pathol 1977; 43: 410-415.
19. Eisen D. The evaluation of cutaneous, genital, scalp,
nail, esophageal, and ocular involvement in patients
with oral lichen planus. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 1999; 88: 431-436.
20. Lozada-Nur F, Miranda C, Maliksi R. Double-blind
clinical trial of 0.05% clobetasol propionate (corrected
from proprionate) ointment in orabase and 0.05%
fluocinonide ointment in orabase in the treatment of
patients with oral vesiculoerosive diseases. Oral Surg
Oral Med Oral Pathol 1994; 77: 598-604.
21. Conrotto D, Carbone M, Carrozzo M, et al. Cyclosporin
vs. clobetasol in the topical management of atrophic
and erosive oral lichen planus: a double-blind,
randomized controlled trial. Br J Dermatol 2006; 154:
139-145.
Thank you for copying data from http://www.arastirmax.com
